Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $681.87 billion, total revenue of $169.34 billion and a weighted average PE ratio of 39.13.
Market Cap
681.87B
Revenue
169.34B
Profits
17.43B
PE Ratio
39.13
Profit Margin
10.29%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 175.70B | -1.91% | 1,728,124 | 45.20B |
| 2 | DHR | Danaher Corporation | 130.44B | -1.25% | 3,305,485 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.34B | -0.46% | 459,046 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.25B | -2.12% | 2,201,123 | 7.23B |
| 5 | WAT | Waters Corporation | 35.87B | -2.95% | 676,514 | 3.77B |
| 6 | NTRA | Natera, Inc. | 30.84B | -3.06% | 847,664 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 30.62B | -1.84% | 1,279,041 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 24.56B | -3.42% | 2,061,540 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.33B | -2.22% | 255,120 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.17B | 2.13% | 815,987 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.74B | 1.60% | 429,275 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 16.66B | -5.60% | 3,345,388 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.97B | -0.97% | 190,541 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 11.44B | -2.19% | 1,348,933 | 8.25B |
| 15 | RVTY | Revvity, Inc. | 10.97B | -3.94% | 868,561 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.73B | -2.40% | 519,308 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.59B | -2.34% | 1,412,829 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 4.47B | -7.08% | 879,535 | 354.54M |
| 19 | SHC | Sotera Health Company | 4.45B | 0.32% | 2,092,471 | 1.19B |
| 20 | TWST | Twist Bioscience Corporation | 4.31B | -6.37% | 2,474,171 | 409.48M |
| 21 | RDNT | RadNet, Inc. | 4.27B | 2.90% | 960,545 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 3.89B | -2.42% | 1,168,485 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 2.70B | -6.53% | 2,164,035 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.57B | -9.87% | 760,274 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.55B | -7.22% | 1,182,402 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.42B | -3.63% | 1,047,127 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.15B | -3.76% | 548,319 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.13B | -11.16% | 4,148,751 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.09B | -1.37% | 3,947,919 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 637.23M | -2.41% | 212,464 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 543.87M | -1.79% | 374,981 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 431.63M | -2.56% | 1,153,226 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 334.21M | -4.47% | 197,584 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 169.19M | -20.00% | 292,195 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 156.28M | -6.30% | 33,895 | 96.10M |
| 36 | XGN | Exagen Inc. | 103.65M | -10.44% | 371,181 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 97.13M | 0.55% | 17,327 | 77.14M |
| 38 | PRPO | Precipio, Inc. | 41.93M | 0.56% | 22,939 | 25.83M |
| 39 | MDXH | MDxHealth SA | 29.07M | -5.68% | 1,011,797 | 110.97M |
| 40 | QUCY | Quantum Cyber N.V. | 27.53M | -5.58% | 1,916,827 | 537.08K |
| 41 | XWEL | XWELL, Inc. | 11.48M | -2.17% | 115,759 | 28.83M |
| 42 | MBAI | Check-Cap Ltd. | 10.06M | -8.00% | 105,996 | - |
| 43 | BIAF | bioAffinity Technologies, Inc. | 7.84M | -7.98% | 229,462 | 5.66M |
| 44 | ADVB | Advanced Biomed Inc. | 6.89M | -2.11% | 6,568 | - |
| 45 | NOTV | Inotiv, Inc. | 5.79M | 91.80% | 1,066,872,941 | 507.36M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.25M | -11.32% | 7,414 | - |
| 47 | ISPC | iSpecimen Inc. | 4.34M | -5.03% | 54,996 | 1.03M |